The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy

Journal of Pathology

Volumn 234, Issue 2, 2014, Pages 164-177

  Klingel, Karin ^a   Fabritius, Cornelia ^b   Sauter, Martina ^a   Göldner, Katrin ^b   Stauch, Diana ^b   Kandolf, Reinhard ^a   Ettischer, Nicole ^a   Gahlen, Sabine ^a   Schönberger, Tanja ^a   Ebner, Susanne ^c   Makrigiannis, Andrew P ^d   Bélanger, Simon ^d   Diefenbach, Andreas ^e   Políc, Bojan ^f   Pratschke, Johann ^c   Kotsch, Katja ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF OTTAWA   (Canada)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Natural killer cells; NKG2D; Virus induced cardiomyopathy

Indexed keywords

GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; COXSACKIEVIRUS B3 MYOCARDITIS; CYTOKINE RELEASE; DEGRANULATION; ECHOCARDIOGRAPHY; HAPLOTYPE; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE INJURY; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SPLEEN; VIRAL CLEARANCE; VIRUS MYOCARDITIS; VIRUS REPLICATION; VIRUS RESISTANCE; ANIMAL; C57BL MOUSE; CARDIOMYOPATHY; COXSACKIE VIRUS INFECTION; ENTEROVIRUS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MYOCARDITIS; NATURAL KILLER CELLS; NKG2D; PATHOLOGY; VIROLOGY; VIRUS-INDUCED CARDIOMYOPATHY;

NATURAL KILLER CELLS; NKG2D; VIRUS-INDUCED CARDIOMYOPATHY;

ANIMALS; CARDIOMYOPATHIES; CD8-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS; INFLAMMATION; KILLER CELLS, NATURAL; MALE; MICE, INBRED C57BL; MYOCARDITIS; MYOCARDIUM; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84907957309     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4369     Document Type: Article

References (32)

1. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99: 1091-1100.
2. Westermann D, Savvatis K, Lindner D, et al. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation 2011; 124: 2082-2093.
3. Cheung C, Marchant D, Walker EK, et al. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 2008; 117: 1574-1582.
4. Klingel K, Hohenadl C, Canu A, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heartmuscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 1992; 89: 314-318.
5. Godeny EK, Gauntt CJ. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 1986; 137: 1695-1702.
6. Gauntt CJ, Godeny EK, Lutton CW, et al. Role of natural killer cells in experimental murine myocarditis. Springer Semin Immunopathol 1989; 11: 51-59.
7. Yokoyama WM. Natural killer cell receptors. Curr Opin Immunol 1998; 10: 298-305.
8. Kärre K, Ljunggren HG, Piontek G, et al. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319: 675-678.
9. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nature Rev Immunol 2003; 3: 781-790.
10. Jamieson AM, Diefenbach A, McMahon CW, et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002; 17: 19-29.
11. Malarkannan S, Shih PP, Eden PA, et al. The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol 1998; 161: 3501-3509.
12. Cerwenka A, Bakker AB, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12: 721-727.
13. Carayannopoulos LN, Naidenko OV, Fremont DH, et al. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 2002; 169: 4079-4083.
14. Gasser S, Orsulic S, Brown EJ, et al. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436: 1186-1190.
15. Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene 2008; 27: 5944-5958.
16. Fang M, Lanier LL, Sigal LJ. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog 2008; 4: e30.
17. Zafirova B, Mandaríc S, Antulov R, et al. Altered NK cell development and enhanced NK cell-mediated resistance to MCMV in NKG2D-deficient mice. Immunity 2009; 31: 270-282.
18. Szalay G, Sauter M, Haberland M, et al. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 2009; 104: 851-859.
19. Szalay G, Sauter M, Hald J, et al. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 2006; 169: 2085-2093.
20. Gruhle S, Sauter M, Szalay G, et al. The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression. Basic Res Cardiol 2012; 107:287-299.
21. Kandolf R, Hofschneider PH. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A 1985; 82: 4818-4822.
22. Chiossone L, Chaix J, Fuseri N, et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009; 113: 5488-5496.
23. Kim S, Iizuka K, Kang HS, et al. In vivo developmental stages in murine natural killer cell maturation. Nature Immunol 2002; 3: 523-528.
24. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15-22.
25. Kemball CC, Harkins S, Whitmire JK, et al. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog 2009; 5: e1000618.
26. Klingel K, Schnorr JJ, Sauter M, et al. Beta2-microglobulinassociated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol 2003; 162: 1709-1720.
27. Weinzierl AO, Szalay G, Wolburg H, et al. Effective chemokine secretion by dendritic cells and expansion of cross presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 2008; 82: 8149-8160.
28. Ferlazzo G, Tsang ML, Moretta L, et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195: 343-351.
29. Gerosa F, Gobbi A, Zorzi P, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005; 174: 727-734.
30. Ebihara T,Masuda H, Akazawa T, et al. Induction ofNKG2Dligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol 2007; 19: 1145-1155.
31. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101-105.
32. Hamerman JA, Ogasawara K, Lanier LL. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004; 172: 2001-2005.